Category:
Prophylactic Biological Products
CAS NO:
2346620-55-9
Standard:
In-house Standards,
Molnupiravir is an oral antiviral agent designed for the treatment of mild-to-moderate COVID-19. It functions as a prodrug that induces lethal mutagenesis in viral RNA replication. The compound features the molecular formula C15H24N4O8 and carries CAS registry number 1678302-64-1.
Strictly contraindicated for pregnant individuals due to teratogenic risks. Storage requires controlled conditions below 30°C in moisture-proof containers. Regulatory approval varies by jurisdiction, necessitating compliance with local pharmacopoeia standards.